Amlodipine and olmesartan medoxomil tablets
Reason category: Dissolution failure
FDA recall number D-0045-2027
Blood pressure
Amlodipine 5 mg tablet
Public data on amlodipine from CMS and FDA: what pharmacies have paid for it, how many generic applications FDA has approved, and whether it appears in FDA's shortage or recall records.
$0.0101
NADAC per ea (2026-11)
approximate acquisition cost, not a retail price
-17%
change over five years
peak $0.0219 in 2013-11
39
approved generic applications (ANDAs) on record for Amlodipine Besylate
19 with a product still marketed · first 2005
Not listed
in FDA's current shortage list
no matching FDA shortage entries
NADAC per unit, monthly
AMLODIPINE BESYLATE 5 MG TABShow as table
| Month | NADAC per unit ($) |
|---|---|
| 2013-11 | 0.02188 |
| 2014-02 | 0.02084 |
| 2014-05 | 0.02008 |
| 2014-08 | 0.01997 |
| 2014-11 | 0.01899 |
| 2015-02 | 0.01924 |
| 2015-05 | 0.02033 |
| 2015-08 | 0.02035 |
| 2015-11 | 0.01946 |
| 2016-02 | 0.01924 |
| 2016-05 | 0.01938 |
| 2016-08 | 0.01874 |
| 2016-11 | 0.01853 |
| 2017-02 | 0.01698 |
| 2017-05 | 0.01685 |
| 2017-08 | 0.01564 |
| 2017-11 | 0.01491 |
| 2018-02 | 0.01554 |
| 2018-05 | 0.01556 |
| 2018-08 | 0.01330 |
| 2018-11 | 0.01319 |
| 2019-02 | 0.01222 |
| 2019-05 | 0.01219 |
| 2019-08 | 0.01444 |
| 2019-11 | 0.01375 |
| 2020-02 | 0.01326 |
| 2020-05 | 0.01335 |
| 2020-08 | 0.01247 |
| 2020-11 | 0.01146 |
| 2021-02 | 0.01165 |
| 2021-05 | 0.01189 |
| 2021-08 | 0.01201 |
| 2021-11 | 0.01218 |
| 2022-02 | 0.01116 |
| 2022-05 | 0.01073 |
| 2022-08 | 0.01099 |
| 2022-11 | 0.01179 |
| 2023-02 | 0.01061 |
| 2023-05 | 0.01146 |
| 2023-08 | 0.00981 |
| 2023-11 | 0.01054 |
| 2024-02 | 0.01423 |
| 2024-05 | 0.00993 |
| 2024-08 | 0.01016 |
| 2024-11 | 0.01043 |
| 2025-02 | 0.01060 |
| 2025-05 | 0.01120 |
| 2025-08 | 0.01147 |
| 2025-11 | 0.01111 |
| 2026-02 | 0.01096 |
| 2026-05 | 0.01042 |
| 2026-08 | 0.01021 |
| 2026-11 | 0.01015 |
Source: CMS NADAC weekly files, generic rows, monthly median of weekly averages · data as of 2026-11. Figures can change and may contain errors in the source data. Check the original source before relying on them.
Recall records mentioning amlodipine
openFDA enforcement records, by year reported.
| 2026 | 4 |
| 2025 | 2 |
| 2023 | 1 |
| 2022 | 1 |
| 2021 | 1 |
| 2020 | 2 |
| 2019 | 7 |
| 2018 | 30 |
| 2017 | 1 |
| 2016 | 5 |
97 records since 2012. A record is one product or lot, not one recall event. Combination products that contain amlodipine are included.
What these numbers mean
NADAC is what retail pharmacies pay on average to buy the drug, published by CMS. It does not include rebates and is not what you pay at the counter. ANDA counts include all strengths and forms and applications whose products are now discontinued.
Most recent recall records
Telmisartan and amlodipine tablets
Reason category: Potency out of spec
FDA recall number D-0049-2027
Amlodipine and olmesartan medoxomil tablets
Reason category: Dissolution failure
FDA recall number D-0712-2026
Amlodipine and olmesartan medoxomil tablets
Reason category: Dissolution failure
FDA recall number D-0556-2026
Amlodipine and olmesartan medoxomil tablets
Reason category: Dissolution failure
FDA recall number D-0576-2025
Not health advice. GxRadar is for general information only. Nothing here is medical, pharmacy, legal or financial advice. Do not start, stop or change any medicine based on this site. Talk to your pharmacist or prescriber about your own situation.
Articles that mention amlodipine
28 GxRadar articles cite or discuss this drug.
Price histories · Data story · 5 min
The cheapest pills in GxRadar's 47-drug price basket
Seven of the 47 generics we track cost pharmacies under 2 cents a unit in October 2026, led by amlodipine at 1.02 cents. Which drugs sit at the floor, how long they have been there, and what the ranking does not show.
Price histories · Data story · 5 min
What pharmacies pay for seven blood pressure generics, 2014 and 2026
At federal survey rates, 365 tablets each of seven common blood pressure generics cost pharmacies about $95 in October 2026, down from $1,403 in October 2014. One drug explains most of the drop.
Benchmarks & how prices are set · Explainer · 5 min
How pharmacy dispensing fees work
Medicaid pays pharmacies a per-prescription fee built from state cost surveys, mostly $10 to $11 in 2026. Medicare drug plans negotiate their own, which federal advisers describe as typically a fixed amount such as $1.
Benchmarks & how prices are set · Explainer · 6 min
The federal upper limit, Medicaid's ceiling on generic drug payments
The FUL caps Medicaid spending on generics at 175 percent of average manufacturer prices, or at pharmacy cost when that is higher. In October 2026 the pharmacy-cost floor set it for 59 percent of drug groups.
Labels & identifiers · Explainer · 7 min
Where the lot number and expiration date sit on a medicine package
What federal rules require of the lot number and expiration date, how they fit into the DSCSA 2D barcode, and why recalls are organized around them.
Benchmarks & how prices are set · Data story · 6 min
The brand-generic gap in NADAC
In CMS's Oct. 28, 2026 cost file, brand tablets and capsules cost pharmacies a median 21 times the matching generic. For amlodipine the multiple was 857. Where the gap is widest, and where it nearly closes.